Halozyme To Report First Quarter 2023 Financial and Operating Results
Go back to Halozyme To Report First Quarter 2023 Financial and Operating Results| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 103.12 +17.36 (20.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.76 | 52 Week High | $18.39 | |||
| Open | $90.00 | 52 Week Low | $6.96 | |||
| Day High | $103.30 | P/E | N/A | |||
| Day Low | $90.00 | EPS | $-0.58 | |||
| Volume | 7,833,249 | |||||
